16th World ADC London

World ADC Europe 2026 is a premier international meeting focused on Antibody-Drug Conjugates (ADCs), targeted therapies and emerging payload modalities for cancer and other serious diseases. The summit is designed to connect leaders from biopharma, biotech and clinical research with technology partners, service providers, investors and regulatory stakeholders to advance ADC science, translational strategies and commercial implementation.

Scheduled to take place in 2026 in London, United Kingdom, World ADC Europe brings together a comprehensive programme of expert keynotes, scientific sessions, panel discussions and networking opportunities. Content focuses on novel linker and payload design, site-specific conjugation, translational pharmacology, clinical development best practices, regulatory strategies, manufacturing scale-up and analytical challenges. This multi-track event offers a platform for sharing the latest data, case studies and strategic insights to accelerate ADC pipelines and foster partnerships across the value chain.